Delivery Order SPE2DR25D3016-SPE2DR26FG1DB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of IMFINZI 500 mg/10 ml vials with a ceiling value of $53,051.40 and a firm fixed price contract type. The order is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a $15,915.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of IMFINZI 500 mg/10 mL vials. The award, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), carries an ultimate completion date of December 1, 2025. The contract was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $7,957.71 to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $18,567.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of IMFINZI 500 mg/10 ml vials. The contract is a non-set-aside competitive award with a completion date of September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of IMFINZI (an oncology medication) in 120 mg/2.4 mL vials with a ceiling value of $6,344.80. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,903.44 to AmerisourceBergen Drug Corp for the supply of IMFINZI (120 mg/2.4 ml vial) on October 24, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $15,915.42. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is to be completed by July 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of IMFINZI 500 mg/10 mL vials with a ceiling value of $33,544.68 and a firm fixed price structure. The order is scheduled for completion by November 28, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a $23,873.04 delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 6, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania location. The award was made without a set-aside designation, reflecting open competition among qualified vendors. This delivery order...
- The Defense Logistics Agency awarded a $23,873.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of IMFINZI (500 mg/10 mL vials). The contract was completed without set-aside designation through open competition and is scheduled for ultimate completion by October 21, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG1DBDelivery Order
The Defense Logistics Agency awarded a $27,986.44 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of IMFINZI 500 mg/10 ml vials. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 9, 2025, to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds extensive contracts with the Defense Logistics Agency's Medical Supply Chain to deliver a comprehensive portfolio of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This specific delivery order for IMFINZI, an oncology treatment, reflects the company's ongoing role in supplying specialized medications to support the Defense Health Agency and other federal healthcare systems through the DLA's pharmaceutical procurement programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.0k | 11/17/25 |